MRC to Fund Diagnostic Test Development

摘要

Leeds University and the Avacta Group have been awarded a ￡3.8 million grant by the Medical Research Council(UK)to develop next generation biosensors to differentiate between bacterial and viral infections and also to determine which bacterial strain has caused the infection so that the correct antibiotic can be quickly administered.This will allow for more targeted use of antibiotics,reducing the number of wrongly prescribed treatments and increasing efficacy for patients,which will contribute to a reduction in antimicrobial resistance(AMR).